HALEON Stock Overview
Haleon Pakistan Limited engages in the research and development, manufacture, marketing, and sale of consumer healthcare products primarily in Pakistan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Haleon Pakistan Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | PK₨230.41 |
| 52 Week High | PK₨234.99 |
| 52 Week Low | PK₨120.00 |
| Beta | 0.50 |
| 1 Month Change | 21.90% |
| 3 Month Change | 11.56% |
| 1 Year Change | 71.05% |
| 3 Year Change | 5.21% |
| 5 Year Change | -9.50% |
| Change since IPO | 254.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| HALEON | PK Personal Products | PK Market | |
|---|---|---|---|
| 7D | 6.9% | -1.4% | 0.5% |
| 1Y | 71.1% | -10.6% | 58.0% |
Return vs Industry: HALEON exceeded the PK Personal Products industry which returned -10.6% over the past year.
Return vs Market: HALEON exceeded the PK Market which returned 58% over the past year.
Price Volatility
| HALEON volatility | |
|---|---|
| HALEON Average Weekly Movement | 6.3% |
| Personal Products Industry Average Movement | 5.2% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in PK Market | 8.3% |
| 10% least volatile stocks in PK Market | 3.3% |
Stable Share Price: HALEON has not had significant price volatility in the past 3 months.
Volatility Over Time: HALEON's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 478 | Farhan Haroon | www.pk-consumerhealthcare.gsk.com |
Haleon Pakistan Limited engages in the research and development, manufacture, marketing, and sale of consumer healthcare products primarily in Pakistan. The company offers products in the areas of pain relief under the Panadol brand; oral health under the Sensodyne and Parodontax brand names; respiratory health under the Panadol CF, Sancos, T-Day, Tandegyl, and Actified brands; nutrition and gastrointestinal health under the CaC-1000 PLUS, ENO, and QalSium-D brand names; and skin health under the Physiogel, Hydrozole, SunBlock 60, Lamisil, Acne Aid, Duofilm, SpectraBan, Brevoxyl, and Oilatum brands. It also exports its products.
Haleon Pakistan Limited Fundamentals Summary
| HALEON fundamental statistics | |
|---|---|
| Market cap | PK₨26.18b |
| Earnings (TTM) | PK₨1.02b |
| Revenue (TTM) | PK₨30.42b |
26.4x
P/E Ratio0.9x
P/S RatioIs HALEON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HALEON income statement (TTM) | |
|---|---|
| Revenue | PK₨30.42b |
| Cost of Revenue | PK₨24.67b |
| Gross Profit | PK₨5.74b |
| Other Expenses | PK₨4.72b |
| Earnings | PK₨1.02b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.72 |
| Gross Margin | 18.88% |
| Net Profit Margin | 3.36% |
| Debt/Equity Ratio | 0% |
How did HALEON perform over the long term?
See historical performance and comparison